# Subject Variability in Two Lots of E5501 Administered to Fed and Fasted Healthy Subjects

> **NCT01327872** · PHASE1 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 84 (actual)

## Conditions studied

- Purpura, Thrombocytopenic, Idiopathic
- Acute Idiopathic Thrombocytopenic Purpura
- Chronic Thrombocytopenia

## Interventions

- **DRUG:** E5501 40 mg 2 x 20-mg tablets, orally, fasted
- **DRUG:** E5501 40 mg 2 x 20-mg tablets, orally, with food
- **DRUG:** E5501 40mg 2 x 20-mg tablets, orally, fasted
- **DRUG:** E5501 40 mg 2 x 20-mg tablets, orally, with food

## Key facts

- **NCT ID:** NCT01327872
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2011-04
- **Final completion:** 2011-06
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2012-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01327872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01327872, "Subject Variability in Two Lots of E5501 Administered to Fed and Fasted Healthy Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01327872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*